FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Yurkowsky Michael
2. Issuer Name and Ticker or Trading Symbol

H-CYTE, INC. [ HCYT ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

201 E KENNEDY BLVD, SUITE 700
3. Date of Earliest Transaction (MM/DD/YYYY)

1/8/2019
(Street)

TAMPA, FL 33602
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/16/2019  P  27500 A$0.14 1498707 (1)D  
Common Stock 12/16/2019  P  7500 A$0.11 1506207 D (2) 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) Includes his deemed ownership of 1,022,009 shares by virtue of his ownership of 0.88% of RMS Shareholders LLC ("RMS"), through his ownership of 50% of YPH Holdings LLC which owns 1.76% of RMS. RMS own 50,925,276 shares of common stock of the Issuer. The reporting person is not a control person of RMS and does not have any voting or dipositive power over the shares of the Issuer owned by RMS. The shares will be distributed to the equity owners of RMS upon the occurrence of certain events. Mr. Yurkowsky disclaims beneficial ownership of the shares owned by RMS.
(2) 15,000 of the shares were purchased by Mr. Yurkowsky's wife and 20,000 were purchased in his son's account. Mr. Yurkowsky is deemed to be the beneficial owner of such shares.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Yurkowsky Michael
201 E KENNEDY BLVD, SUITE 700
TAMPA, FL 33602
X



Signatures
/s/ Michael Yurkowsky12/20/2019
**Signature of Reporting PersonDate

H CYTE (QB) (USOTC:HCYT)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more H CYTE (QB) Charts.
H CYTE (QB) (USOTC:HCYT)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more H CYTE (QB) Charts.